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The herpes simplex virus type 1 (HSV) maturational proteinase is synthesized as a precursor that undergoes two autopro-
teolytic cleavages; one at its (M)aturational site, which eliminates its carboxyl ‘‘tail,’’ and a second at its (R)elease site, which
separates the amino proteolytic half of the precursor from its nonproteolytic carboxyl half. In cytomegalovirus (CMV) the
proteolytic half of the precursor, called assemblin, undergoes a third cleavage at an (I)nternal site that converts it from a
single-chain to a two-chain enzyme that retains activity. The HSV assemblin homolog has no I site and therefore does not
form a counterpart two-chain enzyme. In the work reported here we have cloned and expressed HSV sequences that encode
mimics of the An and Ac subunits of two-chain CMV assemblin. We show that when these HSV sequences are coexpressed
in eukaryotic cells, the resulting subunits associate spontaneously to form an active two-chain enzyme. We also show that
the two-chain HSV enzyme, like the natural one-chain form, retains its marked preference for HSV over CMV substrates,
and that intertypic recombinant two-chain assemblin (e.g., HSV An/CMV Ac) does not form because the cross-species
subunits do not interact. We conclude from these results that (i) there are not intrinsic structural differences in the HSV
assemblin homolog that preclude its functioning as a CMV-like two-chain enzyme, (ii) the substrate selectivity shown by
the single-chain HSV enzyme was not noticeably relaxed in the HSV two-chain mimic, and (iii) the interactive domains,
through which the An and Ac portions of the single-chain enzymes associate, differ between HSV and CMV. q 1997 Academic Press
INTRODUCTION (I)nternal cleavage site (Baum et al., 1993; Burck et al.,
1994; Welch et al., 1993). I-site cleavage occurs near the
The maturational proteinase of herpes simplex virus midpoint of the 28-kDa assemblin and divides it into an
type 1 (VP24, HSV UL26 product) and all other her- amino (An , 15.5 kDa) subunit, which contains the absolutely
pesgroup viruses is synthesized as an enzymatically ac- conserved CD3 Ser and CD2 His, and a carboxyl (Ac , 12.5
tive precursor that undergoes at least two autoproteolytic kDa) subunit that remain associated as an active, two-
cleavages (Liu and Roizman, 1991; Preston et al., 1992; chain enzyme (Holwerda et al., 1994).
Welch et al., 1991). One cleavage, at the (M)aturational When the coding sequences for the An and Ac subunits
site, eliminates the carboxyl end of the precursor and of human CMV (HCMV) and simian CMV (SCMV) assem-
the second cleavage, at the (R)elease site, separates the blins are separately cloned and coexpressed in eukary-
proteolytic amino half of the precursor from the nonpro- otic cells, they associate to form proteolytically active
teolytic carboxyl half. Active site labeling (DiIanni et al., two-chain assemblin (Hall and Gibson, 1996). The ability
1994; Holwerda et al., 1994; Stevens et al., 1994) and site- of the An and Ac subunits to associate spontaneously
directed mutagenesis studies (Cox et al., 1995; Welch et indicates that they are able to fold without prior synthesis
al., 1993) have established that the enzyme is a serine as a one-chain enzyme and may represent distinct do-
proteinase and have identified an absolutely conserved, mains within assemblin. Further support for this notion
essential His as a putative second member of the cata- was provided by the finding that both An and Ac are able
lytic site (Cox et al., 1995; Welch et al., 1993). to rescue inactive mutants of assemblin by intermolecu-
The proteolytic amino half of the cytomegalovirus (CMV) lar complementation (Hall and Gibson, 1997). Two-chain
proteinase, called assemblin, is distinguished from its ho- HCMV assemblin has also been formed in vitro from
mologs in the other herpesgroup viruses by having an bacterially synthesized GST fusion proteins but, in that
case, enzyme activity was obtained only when the An and
Ac subunits were first denatured and then combined and
1 Present address: Dept. of Biological Chemistry, Johns Hopkins Uni- renatured together (O’Boyle et al., 1995). Characterization
versity School of Medicine, 725 North Wolfe Street, Baltimore, MD
of the CMV two-chain assemblins indicated that these21205.
enzymes do not differ significantly in either their catalytic2 To whom correspondence and reprint requests should be ad-
dressed. Fax: (410) 955-3023. E-mail: Wade_Gibson@qmail.bs.jhu.edu. properties or range of substrates when compared with
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one-chain CMV assemblin (Hall and Gibson, 1996; Hol- ml of 21 SDS–PAGE sample buffer (described below) to
the cell layer, and collecting the lysate. Resulting sam-werda et al., 1994; O’Boyle et al., 1995). Thus cleavage
of CMV assemblin does not appear to be a mechanism ples were heated in a boiling water bath for 3 min and
stored at0807 until analyzed by sodium dodecyl sulfate –to alter its substrate specificity as it is in several other
two-chain serine proteinases (Ponting et al., 1992; Tate polyacrylamide gel electrophoresis (SDS–PAGE) and
Western immunoassay.et al., 1987).
The HSV assemblin homolog, in contrast, has no I site The polyclonal antisera anti-N1 (to the N-terminus of
the SCMV pAP), anti-N2 (to the N-terminus of SCMV as-(DiIanni et al., 1993) and shows no evidence of forming
a natural counterpart of CMV two-chain assemblin. In semblin), anti-C2 (to the C-terminus of SCMV assemblin),
and a cocktail of monoclonal antibodies (MAbs) againstaddition, the HSV enzyme has a narrower substrate
range than CMV assemblin. Whereas CMV assemblin the HSV pAP have been described previously, (Schenk
et al., 1991; Welch et al., 1993, 1995). Antiserum 37-93will cleave both CMV and HSV substrates, the HSV en-
zyme is highly specific for HSV substrates (Welch et al., was generated against a synthetic peptide correspond-
ing to residues 4 to 18 of the HSV-1 strain 17 assemblin1995). These differences between the HSV and CMV en-
zymes raised questions of (i) whether there may be intrin- homolog and was made available by R. LaFemina (Merck
Research Labs, West Point, PA). Antisera were used atsic structural differences between the two that could pre-
clude formation of a functional two-chain HSV enzyme, a dilution of 1:40 in 10 mM Tris, 0.9% NaCl, and 5% bovine
serum albumin (No. 126602, Calbiochem, San Diego, CA),and (ii) if a two-chain HSV proteinase could form, would
its substrate specificity be more relaxed than the natural pH 7.4 (TN/BSA), except antiserum 37-93, which was
used at a dilution of 1:500.single-chain enzyme.
To test these questions, and with the objective of learn-
ing more about the functional significance of I-site cleav- Construction of recombinant baculoviruses
age, we attempted to make an artificial two-chain form of
HSV assemblin by cloning and coexpressing the coding Recombinant baculoviruses were made using the Ba-
culogold system (No. 21001K, Pharmingen, La Jolla, CA)sequences for mimics of the CMV An and Ac subunits
and testing for proteolytic activity toward both HSV and as instructed by the manufacturer. CMV and HSV genes
were introduced into the BV genome via either theCMV substrates.
pVL1392 or the pVL1393 transfer vector (O’Reilly et al.,
1992). Construction of the following rBVs has been de-MATERIALS AND METHODS
scribed previously (Hall and Gibson, 1996): BJ26, en-
Cells, viruses, and antisera
codes SCMV An ; MH51, encodes SCMV Ac ; JB2, encodes
SCMV pAP; MH50 encodes HCMV An ; MH52, encodesThe DNA sequences used in these studies were from
HCMV strain AD169, SCMV strain Colburn, and HSV-1 HCMV Ac ; and MH60, encodes the HSV pAP. Construc-
tion of new transfer plasmids is described in the follow-strain 17. Human foreskin fibroblast (HFF) cells were
used to propagate these viruses and to prepare the virus- ing paragraphs.
MH59 encodes the HSV assemblin homolog and wasinfected cell lysates used as markers (Gibson, 1981).
Propagation, plaque assay, and protein expression made by removing the coding sequence for the HSV
assemblin homolog from the plasmid, EV2 (Welch, Vil-studies of recombinant baculoviruses (rBVs) were done
in S. frugiperda cells (Sf9, CRL 1711, American Type Cul- larreal, and Gibson, 1995) by XbaI digestion and ligating
it into the XbaI site of pVL1393.ture Collection, Rockville, MD) grown in suspension at
277 in 100-ml spinner flasks containing supplemented MH61 encodes HSV An and was made by isolating the
441-base pair (bp) XbaI, BglI fragment from EV2 (WelchGrace’s medium (No. 350-1605AJ, GIBCO, Grand Island,
NY) with additions to give 10% fetal calf serum (HyClone, et al., 1995) and using it in a three-way ligation with
pVL1392 cut by XbaI and BamHI, and a set of annealedLogan, UT), 50 mg/ml gentimicin (No. 600-5750AD,
GIBCO), and 125 ng/ml Fungizone (No. 600-5295AE, synthetic oligonucleotides. The sense oligonucleotide
was 5*-GGGCGAGGCGTAATCTAGAG-3* which whenGIBCO). rBVs were plaque purified twice (Carrascosa,
1994; Summers and Smith, 1987); high titer stocks were annealed with its complementary antisense partner gave
the BglI and BamHI overhangs needed for ligation. Aprepared for each (Summers and Smith, 1987) and stored
at 47 protected from light until used. Sf9 cells (2.5 1 stop codon (underlined) was added to terminate HSV An
at Ala139.105 cells/well) were infected in 24-well plates (No. 3047,
Becton–Dickinson Labware, Lincoln Park, NJ) at a multi- MH62 encodes HSV Ac. PCR (Mullis et al., 1986) was
done using native PFU polymerase (No. 600135, Stra-plicity of infection of approximately 5–10 by adding 100
ml of virus in single infections or 50 ml of each virus in tagene, La Jolla, CA) with the manufacturer’s standard
protocol. The sense primer was 5*-CGGTTGGATCCCCA-multiple virus infections. Infected cells were harvested 3
days after infection by aspirating the medium, adding 70 ATGCACCCCGATCGCACGC-3*; it contains a new start
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methionine codon (underlined) adjacent to the codon for
His140. A BamHI site was added for cloning purposes
(double underline). The antisense primer was made to a
sequence just 3* to the multiple cloning site of the EV2
(Welch et al., 1995) plasmid. The PCR product was di-
gested with BamHI and XbaI and ligated into the same
sites in pVL1392. The plasmid was then sequenced be-
tween the BamHI and XbaI sites to confirm that no muta-
tions were introduced during the PCR.
JB3 encodes SCMV assemblin and was made by di-
gesting LM8 (Welch et al., 1991) with XbaI and ligating
the fragment containing the assemblin coding sequence
into the XbaI site of pVL1393.
SDS–PAGE and Western immunoassay FIG. 1. Alignment of CMV and HSV-1 assemblin I-site regions and
termini of recombinant HSV An and Ac . (A) An amino acid sequence
SDS–PAGE was done essentially as described by alignment of the I-site region of CMV and HSV-1 assemblins. The arrow
Laemmli (Laemmli, 1970); the ratio of N,N*-methylene- denotes the known (HCMV; SCMV) or probable (BbCMV; MCMV) I site
of the four sequenced CMV assemblins. The asterisk (*) indicates thebis-acrylamide to acrylamide was 0.735:28. SDS was
position in the HSV assemblin sequence that was selected as a breakfrom Bio-Rad (Melville, NY) and 21 SDS–PAGE sample
point to create recombinant mimics of the CMV amino (An) and carboxylbuffer was 4% SDS, 20% b-mercaptoethanol, 20% glyc-
(Ac) subunits comprising the CMV two-chain enzyme. A gap was intro-
erol, 50 mM Tris (pH 7.0), and 0.02% bromophenol blue. duced into the computer alignment of the MCMV sequence, between
Western immunoassays were done essentially as de- Pro134 and Asp135, to bring the putative P4 Asp into alignment with
those in the other three sequences and to shift the putative I cleavagescribed by Towbin et al. (1979). A semidry transfer unit
site to the first Ala–Ala pair, because the P1* Ala of all other knownwas used; the membrane was Immobilon-P (Millipore,
M, R, and I sites is the first one. (B) The carboxyl end of HSV An andBedford, MA); the buffer was 50 mM Tris, 20% methanol;
the amino terminus of HSV Ac . The underlined ‘‘M’’ is the nonencoded
and the time of transfer was calculated by the formula: Met added to translate HSV Ac .
gel width 1 height 1 2.5  milliamperes per 30 min. The
membrane was blocked in TN/BSA, reacted sequentially
collected by centrifugation (30 sec at 3,000 g), washedwith antiserum and then 125I-protein A, both in TN/BSA,
four times with 200 ml of IP wash buffer (0.5% deoxycho-and exposed to X-ray film, usually with a calcium tung-
late, 1% NP-40, 300 mM KCl in CMF-PBS), and transferredstate intensifying screen (Laskey and Mills, 1977).
to a new tube and washed once more with IP wash
Immunoprecipitation buffer. A volume of 21 SDS–PAGE solubilizing buffer
approximately equal to the bead-pellet volume (i.e., 40
Immunoprecipitations from rBV-infected cells were
ml/tube) was added to the beads and the samples were
done as follows. Approximately 2 1 106 Sf9 cells were heated in a boiling water bath for 3 min and stored at
grown at 277 in 6-cm plastic petri dishes and then in- 0807 until analyzed by SDS–PAGE and Western immu-
fected with one or more recombinant baculoviruses at a noassay.
multiplicity of infection of 5 to 10. Infected cells were
harvested 2 days after infection by removing the medium
RESULTS
and adding 100 ml of 0.5% Nonidet P-40 (NP-40) in 10
mM Tris, pH 7.4, 0.9% NaCl. The disrupted cells were An amino acid sequence alignment of the I-site region
of the CMV assemblins and their HSV homolog is shownscraped from the dish, transferred to a microfuge tube,
and kept on ice for 5 min. The NP-40 nuclear fraction in Fig. 1A. The I site (Fig. 1A, arrow) has been identified
by direct sequence analysis in HCMV (DVEA f ATSL)(pellet) was separated from the NP-40 cytoplasmic frac-
tion (supernatant) by centrifugation (16,000 g, 47, 10 min). (Baum et al., 1993; Burck et al., 1994), and by mutational
analysis in SCMV (DINA f ADGA) (Welch et al., 1993);The resulting NP-40 cytoplasmic fraction was used for
subsequent immunoprecipitation reactions. probable counterparts also occur in the corresponding
regions of baboon CMV (DINA f ADSA) (Gibson et al.,Immunoprecipitations were done by combining 50 ml
of the NP-40 cytoplasmic fraction with 20 ml of anti-C2 1995) and murine CMV (DAVA?AAAA) (Loutsch et al.,
1994). There is little sequence similarity between HSVantiserum, rocking the solution at room temperature for
1.5 hr, and then adding 70 ml of protein A beads (Sigma, and CMV assemblin in this small region between the
highly conserved domains CD1 and CD3, so for purposesSt. Louis, MO; 100 mg/ml in calcium and magnesium
free, phosphate-buffered saline, CMF-PBS) and rocking of constructing recombinant genes encoding HSV mim-
ics of the CMV An and Ac subunits, we defined Ala139the mixture for 1 hr at room temperature. The beads were
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coexpressed with just An or Ac alone (Fig. 2, lanes 4 and
5, respectively).
Although we could detect only An directly (Fig. 5B,
lanes 1 and 2; no antibodies to HSV Ac), the finding that
HSV An is proteolytically active only when coexpressed
with HSV Ac (Fig. 2, lane 7) is taken as reasonable evi-
dence that the HSV Ac subunit is also expressed. Varia-
tion in the amount of pAP in the different samples was
not consistent from experiment to experiment and is at-
tributed to differences in cell numbers among the startingFIG. 2. Recombinant two-chain HSV assemblin analog is an active
samples. It is likely that the reduced amount of pAP rproteinase. Sf9 cells were infected with rBVs encoding HSV pAP, as-
semblin, An , or Ac , either alone or in combination, as described under AP cleavage seen with the two-chain enzyme, compared
Materials and Methods. Lysates of the infected cells were prepared to the single enzyme, is due to the comparatively lower
and subjected to SDS–PAGE in a 10% polyacrylamide gel, followed by efficiency of forming the two-chain enzyme from two in-Western immunoassay using a cocktail of MAbs reactive with the HSV
dependently expressed subunits. These findings are sim-pAP and AP, all as described under Materials and Methods. Shown
ilar to those obtained from coexpression experimentshere is a fluorographic image of the resulting immunoblot. The sample
order is NP-40 cytoplasmic (lane 1) and NP-40 nuclear (lane 2) fractions done with the An and Ac subunits of HCMV and SCMV
of HSV-infected HFFs, wild-type baculovirus-infected cells (lane 3), pAP assemblin (Hall and Gibson, 1996) and indicate that the/ An (lane 4), pAP / Ac (lane 5), pAP alone (lane 6), pAP / An / Ac HSV assemblin homolog is proteolytically active as an(lane 7), and pAP / HSV assemblin homolog (A). The positions of the
artificial recombinant two-chain enzyme.precursor (pAP or ICP35c,d) and mature (AP or ICP35e,f) forms of the
HSV assembly protein are indicated to the right. Band indicated by
asterisk above pAP is believed to be the counterpart of a modified
form of the CMV pAP that increases in amount as expression pro-
Artificial two-chain HSV proteinase has substrategresses (Gibson et al., 1994). Band indicated by lower asterisk is cleav-
specificity comparable to that of the natural single-age product of band above pAP.
chain enzyme
We have shown before that the substrate specificityas the carboxy terminus of our HSV An construct and
of the HSV assemblin homolog is more restricted thanHis140 (following an added translational start methio-
those of HCMV or SCMV (Welch et al., 1995). Whereasnine) as the amino terminus of our HSV Ac construct
HCMV and SCMV assemblins can cleave SCMV, HCMV,(Fig. 1B). Ala139 was selected because it gave the same
and HSV pAP r AP, the HSV enzyme shows a muchcarboxy-terminus for HSV An as is found in all CMV An
stronger preference for its own substrate, to the extentsubunits and because it is approximately the same num-
that its ability to cleave CMV pAP r AP was undetected inber of residues from CD3 as the P1 (Schechter and
transfection assays (Welch et al., 1995), and only becameBerger, 1967) Ala of the CMV I site. The experiments
apparent at the higher expression levels achieved in thedescribed below were done to determine whether these
baculovirus system (e.g., Fig. 3, lane 10). We have showntwo HSV recombinant subunit proteins can associate to
that conversion of one- to two-chain assemblin does notform a substrate-specific two-chain proteinase when
restrict the substrate range of the CMV enzyme; it stillcoexpressed in insect cells.
cleaves both CMV and HSV substrates (Hall and Gibson,
1996). However, because we had no pAP substrates thatCoexpression of HSV An and Ac yields proteolytic
the single-chain enzyme was unable to cleave, we wereactivity
unable to determine whether conversion to the two-chain
form might have given the CMV enzyme a broader sub-The recombinant genes encoding HSV An and Ac were
cloned into baculoviruses, as described under Materials strate range. The restricted range of the HSV assemblin
homolog provided an opportunity to test this possibility.and Methods. Insect cells were infected with an rBV
encoding the HSV pAP (Fig. 2, lane 6) or were coinfected To evaluate the substrate recognition range of the two-
chain HSV enzyme, we tested its ability to cleave SCMVto express the HSV pAP together with (i) the HSV assem-
blin homolog (Fig. 2, lane 8), (ii) HSV An (Fig. 2, lane 4), and HCMV pAPs. This was done by infecting insect cells
with appropriate combinations of rBVs and monitoring(iii) HSV Ac (Fig. 2, lane 5), or (iv) both HSV An and Ac
(Fig. 2, lane 7). Three days after infection the cells were the extent of substrate cleavage by Western immunoas-
say of cell lysates prepared 3 days after infection. Resultsharvested and analyzed by SDS–PAGE and Western im-
munoassay. Results of the experiment showed that sub- showed that although coexpression of HSV [An / Ac]
yielded cleavage of HSV pAP r AP (e.g., Fig. 2, lane 7),strate-specific cleavage (i.e., HSV pAP r AP) occurred
when HSV pAP was coexpressed with both HSV An and coexpression of the HSV subunits together with either
SCMV pAP (Fig. 3, lane 7) or HCMV pAP (data not shown)Ac (Fig. 2, lane 7; also see Fig. 4, lane 6), but not when
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HSV An and CMV Ac do not form a complex when
coexpressed
To examine the possibility that the intertypic two-chain
enzymes were inactive because the cross-species sub-
units did not interact, we coexpressed the HSV An and
HCMV Ac and tested for their interaction by immunopre-
cipitation with anti-C2, specific for CMV Ac (Hall and Gib-
son, 1996), as described under Materials and Methods.
The resulting immunoprecipitates were subjected to
FIG. 3. Recombinant two-chain HSV assemblin analog shows strong SDS–PAGE followed by Western immunoassays using
species specificity similar to the single-chain enzyme. Sf9 cells were anti-C2 to visualize the HCMV Ac subunit, and antiseruminfected with rBVs, processed, subjected to SDS–PAGE in a 10% poly-
37-93 to visualize the HSV An subunit.acrylamide gel, and analyzed by Western immunoassay using anti-N1
The HCMV Ac subunit was immunoprecipitated by anti-(reactive with the SCMV pAP and AP), all as described under Materials
and Methods. Shown here is a fluorographic image of the resulting C2 when expressed alone (Fig. 5A, lane 2) or when coex-
blot. One-chain assemblin is abbreviated ‘‘A’’ (e.g., HSV A). ‘‘a’’ indicates pressed with HSV An (Fig. 5A, lane 3) or when produced
an HSV protein (e.g., aAn is HSV An) and ‘‘s’’ denotes SCMV proteins by I-site cleavage of assemblin (Fig. 5A, lane 5). HCMV
(e.g., sAn is SCMV An). Mock and wtBV are lysates of noninfected and single-chain assemblin was also immunoprecipitated bywild-type baculovirus-infected cells, respectively. Col. Cyto. and Col.
anti-C2 (Fig. 5A, lane 5), as expected, because it containsNuc. are NP-40 cytoplasmic and nuclear fractions of SCMV-infected
HFF cells, shown for reference. The positions of the SCMV pAP and the Ac subunit domain, including the 15 amino acid se-
AP bands are indicated in the right margin. The asterisk is as explained quence used to produce the antiserum. No proteins were
in the legend to Fig. 2. specifically immunoprecipitated by anti-C2 from wild-
type baculovirus-infected cells (Fig. 5A, lane 4). The HSV
An subunit was not coimmunoprecipitated with the HCMVyielded no detectable pAP r AP cleavage. Controls were
Ac subunit (Fig. 5B, lane 7). To confirm that HSV An wasdone to verify that the SCMV and HCMV two-chain as-
present in the starting lysate, it was tested by Westernsemblins had cleaved both the SCMV (Fig. 3, lane 11;
immunoassay using the antiserum 37-93. This immuno-data not shown) and the HCMV pAPs (data not shown),
assay showed that HSV An was present in cells whereas shown before (Hall and Gibson, 1996). Thus, like the
it was expressed alone (Fig. 5B, lane 1) and in cellsnatural HSV single-chain assemblin homolog (Fig. 3, lane
where it was coexpressed with HCMV Ac (Fig. 5B, lane9), the artificial two-chain enzyme showed a strong pref-
2). Only single-chain assemblin was detected when theerence for its own substrate over those of CMV.
HSV assemblin homolog was expressed alone (Fig. 5B,
lane 4), because the natural enzyme does not undergoHSV An and Ac are not interchangeable with their
CMV counterparts
Previously, we showed that the An and Ac subunits of
HCMV and SCMV can be interchanged and still give
active two-chain proteinases (e.g., HCMV An / SCMV Ac
 active hybrid two-chain proteinase) (Hall and Gibson,
1996). To determine whether an intertypic two-chain en-
zyme could be formed, consisting of one HSV subunit
and one CMV subunit, we coexpressed either [SCMV An
/ HSV Ac] or [HSV An / SCMV Ac] together with SCMV
pAP. Neither intertypic combination resulted in SCMV
pAP r AP cleavage (Fig. 3, lanes 12 and 13). FIG. 4. Coexpression of HSV and CMV subunits gives no evidence
of intertypic HSV/CMV two-chain assemblin. Sf9 cells were infectedConsidering that the inability of the intertypic two-chain
with rBVs, harvested, subjected to SDS–PAGE in a 10% polyacrylamideenzymes to cleave SCMV pAP may be due to the strong
gel, and analyzed by Western immunoassay using a cocktail of MAbssubstrate specificity of the HSV enzyme for HSV sub-
reactive with the HSV pAP and AP, all as described under Materials
strates, we also tested their ability to cleave HSV pAP. and Methods. Shown here is a fluorographic image of the resulting
Of the four possible combinations of HSV and CMV sub- blot. HSV A is the single-chain HSV assemblin homolog. ‘‘a’’ indicates
HSV proteins (e.g., aAn is HSV An), ‘‘h’’ and ‘‘s’’ denote HCMV and SCMVunits, none yielded HSV pAP r AP cleavage (Fig. 4, lanes
proteins, respectively. Mock and wt BV are lysates of noninfected and7–9, 12). In contrast, both of the SCMV/HCMV hybrid
wild-type baculovirus-infected cells, respectively. HSV Cyto. and HSVenzymes cleaved HSV pAP r AP (Fig. 4, lanes 11, 13).
Nuc. are NP-40 cytoplasmic and nuclear fractions of HSV-infected HFF
Controls showed that all three homotypic two-chain en- cells, shown for reference. The positions of the HSV pAP and AP homo-
zymes cleaved the HSV pAP r AP (Fig. 4, lanes 6, logs (i.e., ICP35c,d and ICP35e,f) are indicated in the right margin. The
asterisks are as explained in the legend to Fig. 2.10, 14).
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the HSV assemblin homolog to form a two-chain enzyme
accounts for its narrower substrate range, as compared
with CMV assemblins; and (iii) whether intertypic two-
chain assemblins (e.g., CMV An/ HSV Ac) can be formed.
This was accomplished by cloning HSV sequences that
approximate those encoding CMV An and Ac and ex-
pressing them with one another to test for active two-
chain HSV proteinase, or with CMV subunits to test for
active HSV/CMV intertypic two-chain proteinase. Our re-
sults (i) establish that a two-chain HSV assemblin analog
can be formed in insect cells by coexpressing recombi-FIG. 5. HCMV Ac does not coimmunoprecipitate HSV An . Sf9 cells
nant HSV counterparts of the CMV An and Ac subunits,were infected with rBVs encoding wild-type BV, HCMV assemblin
(HCMV A), HSV assemblin (HSV A), HSV An , or HCMV Ac , either alone (ii) show that the two-chain HSV enzyme retains the com-
or in the indicated combinations. The infected cells were processed, paratively restricted substrate range of the single-chain
subjected to SDS–PAGE in 14% polyacrylamide mini-gels, electrotrans- enzyme, and (iii) show that HSV and CMV subunits do
ferred to Immobilon, and probed in a Western immunoassay with either
not associate to form an active intertypic two-chain as-anti-C2 (A) or antiserum 37-93 (B), all as described under Material and
semblin.Methods. (A) The anti-C2 immunoprecipitates after Western immunoas-
say with the anti-C2 antiserum. (B) An immunoimage prepared from The ability of the HSV assemblin homolog to function
the blot showing both the starting lysates (lanes 1–4), and the anti-C2 as a two-chain enzyme indicates that the absence of a
immunoprecipitates after Western immunoassay with the antiserum natural two-chain form is due to the lack of an I site, or
37-93 (lanes 5–10). Shown here is a fluorographic image of the re-
to the inability of the enzyme to recognize and cleave ansulting blot. ‘‘a’’ indicates an HSV protein (i.e., aAn is HSV An), and ‘‘h’’
I-site sequence, or to both. The spontaneous associationdenotes HCMV proteins (i.e., hAc is HCMV Ac). The positions of the
HSV An (aAn) and assemblin (AHSV) and HCMV Ac (hAc) and assemblin of the HSV recombinant subunits within the cell indicates
(hA) are indicated between the panels. Dots indicate the position of that they can assume a suitably interactive conformation
the IgG light chain. without prior synthesis and folding as a single-chain en-
zyme and suggests that they represent structurally and
perhaps functionally distinct domains, as noted beforeI-site cleavage and there are no An and Ac counterparts
with CMV two-chain assemblin (Hall and Gibson, 1996).produced. The absence of detected coimmunoprecipita-
General structural similarities of this sort are expectedtion of HSV An by HCMV Ac indicates that these cross-
among the proteinase homologs of different members ofspecies subunits do not interact to form a two-chain en-
the same virus group (Bazan and Fletterick, 1989).zyme and explains why no pAP r AP cleavage was de-
The inability of the HSV and CMV subunits to interacttected when these HSV and CMV subunits were coex-
and form intertypic two-chain enzymes indicates that thepressed.
interfaces through which An and Ac interact differ be-
tween the HSV and CMV enzymes, or that the cross-DISCUSSION
species subunits are conformationally incompatible, or
both. It may be possible to exploit this incompatability toCMV assemblins appear to be distinguished as a
group by autoproteolytic cleavage at an (I)nternal site map the interactive domains by using chimeras of one
subunit (e.g., HSV An having a specific sequence re-(Baum et al., 1993; Burck et al., 1994; Welch et al., 1993)
that converts the enzyme from a one-chain to a two-chain placed with the corresponding sequence from CMV An) to
identify residues that enable it to interact with a normallyform that retains activity (Holwerda et al., 1994). None
of the a- or g-herpesviruses for which the proteinase incompatable cross-species subunit (e.g., HSV An chi-
mera / CMV Ac) to form active enzyme. Identifying thesesequence is available (Gibson et al., 1995), or even b-
herpesviruses other than the CMVs (e.g., HHV-6, and interactive domains will have importance in understand-
ing assemblin function and possibly providing additionalHHV-7), has an obvious I-site equivalent. Correspond-
ingly, no evidence of a counterpart two-chain enzyme targets for inhibiting the enzyme.
Three lines of evidence now indicate that I-site cleav-has been found among the a- (i.e., HSV-1; Fig. 5B, lane
4) and g-(i.e., EBV) herpesvirus assemblin homologs that age is not likely to be a mechanism for altering enzyme
specificity. The first is that expression of CMV assemblinhave been cloned and expressed (DiIanni et al., 1993;
Donaghy and Jupp, 1995). as just the two-chain form (i.e., coexpression of An and
Ac) did not narrow its substrate range (i.e., still cleavesThe objectives of the work described in this report
were to determine (i) whether there might be intrinsic CMV M, R, and I sites, and HSV M site) (Hall and Gibson,
1996) or appreciably alter its kinetics in vitro (Holwerdadifferences in the non-CMV assemblin homologs, specifi-
cally HSV, that preclude them from functioning as an et al., 1994; O’Boyle et al., 1995). The second is the finding
reported here that expression of the HSV assemblin ho-analogous two-chain enzyme; (ii) whether the inability of
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sequence analysis of autoproteolytic cleavage products. J. Biol.molog as a two-chain enzyme did not broaden its sub-
Chem. 268(3), 2048–2051.strate range (i.e., strong selectivity for HSV substrates
DiIanni, C. L., Stevens, J. T., Bolgar, M., O’Boyle, D. R., Weinheimer, S. P.,
retained). Third, a set of collary experiments to these and Colonno, R. J. (1994). Identification of the serine residue at the
HSV studies showed that when expressed as just the active site of the herpes simplex virus type I protease. J. Biol. Chem.
269(17), 12672–12676.single-chain form (e.g., I-site mutant A127Q unable to be
Donaghy, G., and Jupp, R. (1995). Characterization of the Epstein–Barrcleaved to two-chain enzyme), the substrate range of
virus proteinase and comparison with the human cytomegalovirusSCMV assemblin was not decreased (i.e., still cleaved
proteinase. J. Virol. 69(2), 1265–1270.
CMV M, R, and I sites and HSV M site; M. R. T. Hall and Gibson, W. (1981). Structural and nonstructural proteins of strain Col-
W. Gibson, unpublished data; Welch et al., 1993). An burn cytomegalovirus. Virol. 111, 516–537.
Gibson, W., Welch, A. R., and Hall, M. R. T. (1995). Assemblin, a herpesalternative explanation for its evolutionary retention or
virus serine maturational proteinase and new molecular target forselection is that I-site cleavage is a mechanism to elimi-
antivirals. Persp. Drug Discovery Design 2, 413–426.nate or reduce the amount of assemblin in CMV capsids
Gibson, W., Welch, A. R., and Ludford, J. (1994). Transient transfection
in order to accomodate its comparatively large genome assay of the herpesvirus maturational proteinase, assemblin. Meth-
(i.e., 25% larger than that of Epstein–Barr virus, the ods Enzymol. 244, 399–411.
Hall, M. R. T., and Gibson, W. (1996). Cytomegalovirus assemblin: Thelargest of the characterized non-CMV herpesviruses).
amino and carboxyl domains of the proteinase form active enzymePreliminary findings are consistent with this possibility
when separately cloned and co-expressed in eukaryotic cells. J. Virol.and indicate that, in contrast to virions of HSV that retain
70(8), 5395–5404.
their assemblin homolog VP24 (Davison et al., 1992; Per- Hall, M. R. T., and Gibson, W. (1997). Independently cloned halves of
son et al., 1993), virions of HCMV and SCMV either lack cytomegalovirus assemblin, An and Ac , can restore proteolytic activity
to assemblin mutants by intermolecular complementation. J. Virol.or contain substantially reduced amounts of assemblin (J.
71(2).Borchelt, K. Clopper, and W. Gibson, unpublished data).
Holwerda, B. C., Wittwer, A. J., Duffin, K. L., Smith, C., Toth, M. V., Carr,
L. S., Wiegand, R. C., and Bryant, M. L. (1994). Activity of two-chain
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